Blinatumomab
Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia[1][2][3][4].
Product Specifications
CAS Number
[853426-35-4]
Product Name Alternative
Anatumomab; bscCD19xCD3; AMG-103; MEDI-538; MT-103; BLINCYTO
UNSPSC
12352203
Target
CD19
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/blinatumomab.html
Purity
98.78
Solubility
H2O
Smiles
[Blinatumomab]
Molecular Weight
(54.09 kDa)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P9963/Blinatumomab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P9963/Blinatumomab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items